Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Viet Hong Phan"'
Autor:
Peter Galettis, Jennifer H. Martin, Benjamin D. W. Harris, Stephen Clarke, Euan Walpole, Stephanie E. Reuter, Viet Hong Phan, Vidya Perera, Andrew J. McLachlan, Anneliese Szyc, Kellie A. Charles
Publikováno v:
Clinical Pharmacokinetics. 59:1013-1026
Background: The presence of elevated systemic inflammation in people with advanced non-small cell lung cancer (NSCLC) is associated with significantly shorter survival following carboplatin-based chemotherapy. Objective: This study investigated wheth
Publikováno v:
Supportive Care in Cancer. 23:385-391
Malnutrition and elevated inflammatory markers have a negative impact on clinical outcomes in cancer patients. Few studies have investigated the associations between inflammatory makers, nutritional status and survival. This study investigates the as
Autor:
Stephen Clarke, Viet Hong Phan, Peter Galettis, Anneliese Szyc, Philip Beale, Benjamin Harris, Andrew J. McLachlan, Kellie A. Charles, Vidya Perera
Publikováno v:
Journal of Thoracic Oncology. 12:S896-S897
Autor:
Stephen Clarke, Donald C. McMillan, Melissa M. Moore, Wei Chua, C Tan, Viet Hong Phan, Kellie A. Charles, S Kao
Publikováno v:
Clinical Pharmacology & Therapeutics. 90:475-478
Patient-related factors, especially markers of inflammatory response, are prognostic in many common solid cancers. Here we review how such markers, in particular the acute-phase proteins C-reactive protein and albumin and a differential white cell co
Autor:
Melissa M. Moore, Hongmei Xu, Stephen Clarke, Andrew J. McLachlan, Viet Hong Phan, Micheline Piquette-Miller
Publikováno v:
Expert Opinion on Drug Metabolism & Toxicology. 5:243-257
There is wide inter-individual variability in the pharmacokinetics, pharmacodynamics and tolerance of anticancer drugs. Recent evidence suggests that there is even greater variability between individuals of different ethnicity. Allelic variants of ge
Publikováno v:
Expert opinion on drug metabolismtoxicology. 7(11)
Based on recent emerging evidence of inter-ethnic differences in drug response and toxicity, ethnic diversity in pharmacokinetics, pharmacogenomics and clinical outcomes are being increasingly investigated. Ultimately, this will promote improved unde
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Steven Kao, Ashanya Malalasekera, Cindy Tan, Janette L. Vardy, Viet Hong Phan, Stephen Clarke, Po Yee Yip
Publikováno v:
Cancer Treatment Communications. :17-21
BackgroundOncologists use Eastern Cooperative Oncology Group (ECOG) performance score to assess patients' performance status (PS) and guide treatment decisions, but patients may not necessarily agree on their scores. We compared PS scores assessed by